Real-world Data-based Adverse Drug Reactions Analysis of Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world Data-based Adverse Drug Reactions Analysis of Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Published:2022-09-30 Issue:2 Volume:14 Page:149-157
ISSN:2005-3622
Container-title:Journal of Pharmacoepidemiology and Risk Management
language:en
Short-container-title:Journal of Pharmacoepidemiology and Risk Management

Author:

Ko Minoh¹,Choi Jieun²,Kim Sujin²,Kim Sung Hwan²,Cho Eun Jung²,Cho Yoon Sook²,Koh Young Il³,Oh Jung Mi¹

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

2. Department of Pharmacy, Seoul National University Hospital, Seoul, Korea

3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

Publisher

Korean Society for Pharmacoepidemiology and Risk Management

Link

http://pdf.medrang.co.kr/JPERM/2022/014/JPERM014-02-07.pdf

Reference20 articles.

1. Multiple Myeloma

2. Recent advances in multiple myeloma: a Korean perspective

3. The Diagnosis and Treatment of Multiple Myeloma

4. Treatment of relapsed multiple myeloma: Evidence-based recommendations

5. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP